Exchange: NASDAQ·Updated 07:39 PM EDT
ILMN logo

ILMNIllumina Inc

$190.20
$3.56
(1.84%)
Today
Closed $190.20
$0.19
(0.10%)
After Hours
EarningsJul 30
Mkt Cap$28.78B
Vol1.08M
News
all
press releases
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
Biotech is gaining momentum as healthcare leads higher, with several drugmakers and life sciences companies showing improving earnings trends and breakouts.
Zacks
News Placeholder
More News
News Placeholder
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 PR Newswire SAN DIEGO, July 9, 2026 SAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that...
PR Newswire
News Placeholder
Stocks Look Shaky, But This Sector is Booming (Biotech)
Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.
Zacks
News Placeholder
Illumina (ILMN) Is Up 6.87% in One Week: What You Should Know
Does Illumina (ILMN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
News Placeholder
Illumina Stock Gains 43.7% in 2026: What's Powering the Rally?
ILMN stock's 43.7% 2026 rally is fueled by strong sequencing demand, NovaSeq X momentum and progress toward higher growth and profitability.
Zacks
News Placeholder
Here's Why Illumina (ILMN) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer PR Newswire SAN DIEGO, July 9, 2026 New leaders bring extensive leadership experience across life...
PR Newswire
News Placeholder
Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs
Rising use of automation in healthcare is reshaping robotics ETFs as med-tech innovators gain prominence.
Zacks
News Placeholder
EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?
EXEL vs. ILMN: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?
Illumina (ILMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
<
1
2
...
>

Advertisement|Remove ads.